VIATRIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.97 USD | -0.50% |
|
-1.70% | +1.29% |
Presentation Operator MessageOperator (Operator)Good morning and welcome to the Viatris Q1 202...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as the Companyâs ARV franchise. Its portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas, including key brands and generics, including complex products. It operates around 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
10.98
USD
Average target price
12.33
USD
Spread / Average Target
+12.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.29% | 13.07B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +13.79% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- VTRS Stock
- News Viatris Inc.
- Transcript : Viatris Inc., Q1 2024 Earnings Call, May 09, 2024
